Text Size

HISTOACRYL: A Study of Its Efficacy in Final Scar Formation

This study has been completed.
Sponsor:
Collaborator:
Aesculap AG
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00890578
First received: April 29, 2009
Last updated: June 19, 2012
Last verified: June 2012
History of Changes
  Purpose

The use of tissue adhesives for the closure of surgical incisions is becoming increasingly common. Several publications exist purporting the equivalence of tissue adhesive to suture with regard to dehiscence, infection, and cosmesis. Two of the most frequently used adhesives are Histoacryl© and Dermabond©. Despite their popularity, only one study exists comparing the two. In this non-English study only small wounds in an exclusively pediatric population were studied (12). Operative time, cost, and objective measures of scar size were not examined. In the present study we aim to evaluate the relatively large surgical incisions resulting from breast reduction, mastopexy, panniculectomy, and abdominoplasty closed with either Histoacryl©, Dermabond©, or subcuticular suture. The primary aim is to investigate differences in time to wound closure. Secondary aims are to compare the three approaches with respect to cost, dehiscence, infection, scar size, and cosmesis.


Condition Intervention Phase
Surgical Incisions
 Procedure: adhesive to suture
 Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: It is Our Intent to Conduct a Prospective Randomized Controlled Trial Examining the Use of Histoacryl© in the Closure of Surgical Incisions in Comparison to Subcuticular Suture and to Dermabond©.

Resource links provided by NLM:

MedlinePlus related topics: Scars
U.S. FDA Resources

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Comparison of Histoacryl© to Dermabond© is lacking. Investigation of Histoacryl© in direct comparison to Dermabond© as well as to suture. [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Enrollment: 21
Study Start Date: April 2009
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1-abdominal
half abdominal surgeries (20 patients out of 40)
 Procedure: adhesive to suture
surgical closure
Other Name: Dermabond, Histoacryl, or sutures --patients could be randomized to.
2-breast
half breast surgeries (20 out of 40)
 Procedure: adhesive to suture
surgical closure
Other Name: Dermabond, Histoacryl, or sutures --patients could be randomized to.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

1) and 2): Reduction Mammoplasty or mastopexy patients: Patients who present to the plastic surgery clinic and are scheduled for breast procedures will be recruited and consented by a clinical studies co-ordinator. This will include patients undergoing a standard Wise pattern reduction mammoplasty (reduction and lift) or a standard Wise pattern mastopexy (lift only). See exclusion criteria below.

1) and 2): Abdominoplasty or panniculectomy patients: Patients who present to the plastic surgery clinic and are scheduled for abdominal procedures will be recruited and consented by a clinical studies coordinator. See exclusion criteria below.

Criteria

Inclusion Criteria:

  • Age: Younger than 21
  • Gender: Females only. Given the nature of the procedures, as well as our clinical experience, we cannot anticipate recruiting enough male patients to be able to evaluate them as a subgroup. Since there may be differences in distributions of measures, to keep the groups more homogeneous we plan to recruit only females from the outset. Having either:

  • Reduction Mammoplasty or mastopexy patients:

    • Patients who present to the plastic surgery clinic and are scheduled for breast procedures will be recruited and consented by a clinical studies co-ordinator.
    • This will include patients undergoing a standard Wise pattern reduction mammoplasty (reduction and lift) or a standard Wise pattern mastopexy (lift only). See exclusion criteria below.

  • Abdominoplasty or panniculectomy patients:

    • Patients who present to the plastic surgery clinic and are scheduled for abdominal procedures will be recruited and consented by a clinical studies coordinator. See exclusion criteria below.

Exclusion Criteria:

  • Though women of childbearing age will be allowed to participate in this study, no pregnant patients will be enrolled.

  • Patients with any factors that may have an adverse effect on wound healing:

    • previous hypertrophic scars or keloid
    • known vitamin C deficiency
    • known zinc deficiency
    • smoking
    • steroid use
    • known connective tissue disorder
    • hypoalbuminemia
    • any factor not listed that the attending consultant seeing the patient feels would adversely effect wound healing.
  • Patients who have a known sensitivity to adhesives
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00890578

Locations
United States, Florida
Mayo Clinic Florida
Jacksonville, Florida, United States, 32224
Sponsors and Collaborators
Mayo Clinic
Aesculap AG
Investigators
Principal Investigator: Galen Perdikis, M.D. Mayo Clinic
  More Information

No publications provided

Responsible Party: Galen Perdikis, M.D., Mayo Clinic
ClinicalTrials.gov Identifier: NCT00890578     History of Changes
Other Study ID Numbers: 08-007642
Study First Received: April 29, 2009
Last Updated: June 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:
Histoacryl
closure of surgical incisions

ClinicalTrials.gov processed this record on May 19, 2013